These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

247 related articles for article (PubMed ID: 27452520)

  • 1. Synergistic functions of E2F7 and E2F8 are critical to suppress stress-induced skin cancer.
    Thurlings I; Martínez-López LM; Westendorp B; Zijp M; Kuiper R; Tooten P; Kent LN; Leone G; Vos HJ; Burgering B; de Bruin A
    Oncogene; 2017 Feb; 36(6):829-839. PubMed ID: 27452520
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synergistic function of E2F7 and E2F8 is essential for cell survival and embryonic development.
    Li J; Ran C; Li E; Gordon F; Comstock G; Siddiqui H; Cleghorn W; Chen HZ; Kornacker K; Liu CG; Pandit SK; Khanizadeh M; Weinstein M; Leone G; de Bruin A
    Dev Cell; 2008 Jan; 14(1):62-75. PubMed ID: 18194653
    [TBL] [Abstract][Full Text] [Related]  

  • 3. E2F7 Is a Potent Inhibitor of Liver Tumor Growth in Adult Mice.
    Moreno E; Toussaint MJM; van Essen SC; Bongiovanni L; van Liere EA; Koster MH; Yuan R; van Deursen JM; Westendorp B; de Bruin A
    Hepatology; 2021 Jan; 73(1):303-317. PubMed ID: 32259305
    [TBL] [Abstract][Full Text] [Related]  

  • 4. E2F7 and E2F8 keep the E2F family in balance.
    Moon NS; Dyson N
    Dev Cell; 2008 Jan; 14(1):1-3. PubMed ID: 18194644
    [TBL] [Abstract][Full Text] [Related]  

  • 5. DNA-damage response control of E2F7 and E2F8.
    Zalmas LP; Zhao X; Graham AL; Fisher R; Reilly C; Coutts AS; La Thangue NB
    EMBO Rep; 2008 Mar; 9(3):252-9. PubMed ID: 18202719
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Atypical E2Fs inhibit tumor angiogenesis.
    Weijts BGMW; Westendorp B; Hien BT; Martínez-López LM; Zijp M; Thurlings I; Thomas RE; Schulte-Merker S; Bakker WJ; de Bruin A
    Oncogene; 2018 Jan; 37(2):271-276. PubMed ID: 28925392
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cyclin F-dependent degradation of E2F7 is critical for DNA repair and G2-phase progression.
    Yuan R; Liu Q; Segeren HA; Yuniati L; Guardavaccaro D; Lebbink RJ; Westendorp B; de Bruin A
    EMBO J; 2019 Oct; 38(20):e101430. PubMed ID: 31475738
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Atypical E2Fs either Counteract or Cooperate with RB during Tumorigenesis Depending on Tissue Context.
    Moreno E; Pandit SK; Toussaint MJM; Bongiovanni L; Harkema L; van Essen SC; van Liere EA; Westendorp B; de Bruin A
    Cancers (Basel); 2021 Apr; 13(9):. PubMed ID: 33922435
    [TBL] [Abstract][Full Text] [Related]  

  • 9. E2f8 mediates tumor suppression in postnatal liver development.
    Kent LN; Rakijas JB; Pandit SK; Westendorp B; Chen HZ; Huntington JT; Tang X; Bae S; Srivastava A; Senapati S; Koivisto C; Martin CK; Cuitino MC; Perez M; Clouse JM; Chokshi V; Shinde N; Kladney R; Sun D; Perez-Castro A; Matondo RB; Nantasanti S; Mokry M; Huang K; Machiraju R; Fernandez S; Rosol TJ; Coppola V; Pohar KS; Pipas JM; Schmidt CR; de Bruin A; Leone G
    J Clin Invest; 2016 Aug; 126(8):2955-69. PubMed ID: 27454291
    [TBL] [Abstract][Full Text] [Related]  

  • 10. E2F8 is essential for polyploidization in mammalian cells.
    Pandit SK; Westendorp B; Nantasanti S; van Liere E; Tooten PC; Cornelissen PW; Toussaint MJ; Lamers WH; de Bruin A
    Nat Cell Biol; 2012 Nov; 14(11):1181-91. PubMed ID: 23064264
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interaction of E2F7 transcription factor with E2F1 and C-terminal-binding protein (CtBP) provides a mechanism for E2F7-dependent transcription repression.
    Liu B; Shats I; Angus SP; Gatza ML; Nevins JR
    J Biol Chem; 2013 Aug; 288(34):24581-9. PubMed ID: 23853115
    [TBL] [Abstract][Full Text] [Related]  

  • 12. E2F7 can regulate proliferation, differentiation, and apoptotic responses in human keratinocytes: implications for cutaneous squamous cell carcinoma formation.
    Endo-Munoz L; Dahler A; Teakle N; Rickwood D; Hazar-Rethinam M; Abdul-Jabbar I; Sommerville S; Dickinson I; Kaur P; Paquet-Fifield S; Saunders N
    Cancer Res; 2009 Mar; 69(5):1800-8. PubMed ID: 19223542
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression and prognostic role of E2F transcription factors in high-grade glioma.
    Yu H; Li Z; Wang M
    CNS Neurosci Ther; 2020 Jul; 26(7):741-753. PubMed ID: 32064771
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chk1 and 14-3-3 proteins inhibit atypical E2Fs to prevent a permanent cell cycle arrest.
    Yuan R; Vos HR; van Es RM; Chen J; Burgering BM; Westendorp B; de Bruin A
    EMBO J; 2018 Mar; 37(5):. PubMed ID: 29363506
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characterization of E2F8, a novel E2F-like cell-cycle regulated repressor of E2F-activated transcription.
    Christensen J; Cloos P; Toftegaard U; Klinkenberg D; Bracken AP; Trinh E; Heeran M; Di Stefano L; Helin K
    Nucleic Acids Res; 2005; 33(17):5458-70. PubMed ID: 16179649
    [TBL] [Abstract][Full Text] [Related]  

  • 16. E2F7, a novel target, is up-regulated by p53 and mediates DNA damage-dependent transcriptional repression.
    Carvajal LA; Hamard PJ; Tonnessen C; Manfredi JJ
    Genes Dev; 2012 Jul; 26(14):1533-45. PubMed ID: 22802528
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cloning and characterization of mouse E2F8, a novel mammalian E2F family member capable of blocking cellular proliferation.
    Maiti B; Li J; de Bruin A; Gordon F; Timmers C; Opavsky R; Patil K; Tuttle J; Cleghorn W; Leone G
    J Biol Chem; 2005 May; 280(18):18211-20. PubMed ID: 15722552
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Feedback regulation between atypical E2Fs and APC/CCdh1 coordinates cell cycle progression.
    Boekhout M; Yuan R; Wondergem AP; Segeren HA; van Liere EA; Awol N; Jansen I; Wolthuis RM; de Bruin A; Westendorp B
    EMBO Rep; 2016 Mar; 17(3):414-27. PubMed ID: 26882548
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Loss of E2F7 expression is an early event in squamous differentiation and causes derepression of the key differentiation activator Sp1.
    Hazar-Rethinam M; Cameron SR; Dahler AL; Endo-Munoz LB; Smith L; Rickwood D; Saunders NA
    J Invest Dermatol; 2011 May; 131(5):1077-84. PubMed ID: 21248772
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical relevance of E2F family members in ovarian cancer--an evaluation in a training set of 77 patients.
    Reimer D; Sadr S; Wiedemair A; Stadlmann S; Concin N; Hofstetter G; Müller-Holzner E; Marth C; Zeimet AG
    Clin Cancer Res; 2007 Jan; 13(1):144-51. PubMed ID: 17200349
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.